Cholestenone 5 alpha-Reductase
"Cholestenone 5 alpha-Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.
| Descriptor ID |
D042944
|
| MeSH Number(s) |
D08.811.682.660.200
|
| Concept/Terms |
Cholestenone 5 alpha-Reductase- Cholestenone 5 alpha-Reductase
- 5 alpha-Reductase, Cholestenone
- Cholestenone 5 alpha Reductase
- alpha-Reductase, Cholestenone 5
- 4-Ene Steroid 5 alpha-Reductase
- 4 Ene Steroid 5 alpha Reductase
- 5 alpha-Reductase
- 5 alpha Reductase
|
Below are MeSH descriptors whose meaning is more general than "Cholestenone 5 alpha-Reductase".
Below are MeSH descriptors whose meaning is more specific than "Cholestenone 5 alpha-Reductase".
This graph shows the total number of publications written about "Cholestenone 5 alpha-Reductase" by people in this website by year, and whether "Cholestenone 5 alpha-Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestenone 5 alpha-Reductase" by people in Profiles.
-
Moinpour CM, Darke AK, Donaldson GW, Thompson IM, Langley C, Ankerst DP, Patrick DL, Ware JE, Ganz PA, Shumaker SA, Lippman SM, Coltman CA. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Jul 04; 99(13):1025-35.
-
Burkman RT. The role of oral contraceptives in the treatment of hyperandrogenic disorders. Am J Med. 1995 Jan 16; 98(1A):130S-136S.
-
Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab. 1993 Nov; 77(5):1203-8.